|Grant Affiliation:||Shattock: Novel Antigens for Mucosal Protection|
|Strategy:||Prophylactic neutralizing Ab|
|Study Type:||Antibody Screening|
|Study Start Date:||2012-06-06|
|Study Made Public:||2013-02-11|
HIV neutralisation by IgG and IgA versions of MAb 2G12
CAVD 370 is an immunogenicity study of monoclonal antibodies.
Sign in to see full information about this study and to download study data.
ProductsNo Products used in study
No non-integrated data is available for this study.